-
Loading metrics
Prospective Immune Dynamics during the First 24 Weeks of Efavirenz Based-Antiretroviral Therapy in HIV-1-Infected Subjects, According to CD4+ T-Cell Counts at Presentation: The IMMUNEF Clinical Trial
- Alessandro Soria,
- Daria Trabattoni,
- Nicola Squillace,
- Veronica Rainone,
- Federica Gnudi,
- Mario Clerici,
- Andrea Gori,
- Alessandra Bandera
x
- Published: February 11, 2015
- https://doi.org/10.1371/journal.pone.0117118